Skip to main content
. 2018 Sep;128(3):485–491. doi: 10.1016/j.radonc.2018.04.018

Table 1.

Patient characteristics and imaging protocol.

Patient Tumor site No. of lesion ROIs Att. corr. FDG-PET MR-based µ-map T2w MRI (TSE) T1w MRI (VIBE) Diffusion-weighted MRI
b = 150 (AP) b = 150 (PA) b = 800 (AP) b = 800 (PA) ADC (d.c.)
#01 OP 2 (✓)b (✓)b (✓)b (✓)b
#02 OP/HP/VAL 3a
#03 HP 2
#04 OP 2a
#05 OP 1
#06 OP/MC 2
#07 BT/UV 2
#08 HP 2
#09 OP 1
#10 HP 1 (✓)c (✓)c (✓)c (✓)c (✓)c

Abbreviations: OP – oropharynx; HP – hypopharynx; VAL – vallecula; MC – mouth cavity; BT – base of tongue; UV – uvula; ROI – region of interest; att. corr. – attenuation corrected; TSE – turbo spin echo; VIBE – volume interpolated breath hold; AP – anteroposterior; PA – posteroanterior; d.c. – distortion corrected.

a

One FDG avid ROI was no RT target; one MR ROI was only weakly PET positive and not considered in PET analysis.

b

Error in MR sequence parameter settings for scan with diagnostic setup.

c

Strong geometric distortions in DW-MRI with RT setup.